.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Express Scripts
US Army
Julphar
Cipla
Chubb
Teva
QuintilesIMS
Federal Trade Commission
Johnson and Johnson

Generated: September 26, 2017

DrugPatentWatch Database Preview

Actavis Llc Company Profile

« Back to Dashboard

What is the competitive landscape for ACTAVIS LLC, and what generic and branded alternatives to ACTAVIS LLC drugs are available?

ACTAVIS LLC has eight approved drugs.

There is one tentative approval on ACTAVIS LLC drugs.

Summary for Applicant: Actavis Llc

Patents:0
Tradenames:7
Ingredients:7
NDAs:8
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Llc
DOCETAXEL
docetaxel
INJECTABLE;INJECTION203551-001Apr 12, 2013APRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Llc
DAPSONE
dapsone
TABLET;ORAL204380-002Mar 23, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Llc
FLUDARABINE PHOSPHATE
fludarabine phosphate
INJECTABLE;INJECTION203738-001Feb 28, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Llc
LEVOLEUCOVORIN CALCIUM
levoleucovorin calcium
POWDER;IV (INFUSION)206516-001Feb 13, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Llc
DAPSONE
dapsone
TABLET;ORAL204380-001Mar 23, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Llc
MELPHALAN HYDROCHLORIDE
melphalan hydrochloride
INJECTABLE;INJECTION206018-001Dec 19, 2016APRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Llc
DOCETAXEL
docetaxel
INJECTABLE;INJECTION203551-002Apr 12, 2013APRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Llc
HYDROXOCOBALAMIN
hydroxocobalamin
INJECTABLE;INJECTION085998-001Approved Prior to Jan 1, 1982RXNoYes► Subscribe► Subscribe► Subscribe
Actavis Llc
DOCETAXEL
docetaxel
INJECTABLE;INJECTION203551-003Apr 12, 2013RXNoNo► Subscribe► Subscribe► Subscribe
Actavis Llc
AZACITIDINE
azacitidine
POWDER;IV (INFUSION), SUBCUTANEOUS208216-001Apr 29, 2016APRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
UBS
US Department of Justice
Fuji
Boehringer Ingelheim
Johnson and Johnson
Accenture
Citi
Deloitte
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot